Rishi Paliwal

Rishi Paliwal

Postdoctoral Research Associate

Texas A&M Rangel College of Pharmacy
1010 W. Ave. B
Kingsville, Texas   78363

Phone: 361-221-0749
Fax: 361-221-0793
paliwal@tamhsc.edu

Education and Training

 Dr. H. S. Gour Central University, India,
Ph.D., Pharmaceutical Science, 2012

Dr. H. S. Gour Central University, India,
M.Pharm, Pharmaceutics, 2007

Dr. H. S. Gour Central University, India,
B.Pharm, 2004

Physics and Chemistry, Bundelkhand University, Jhansi, India,
B.Sc., 2000

Research Interests

  • Presently, I am working on a non-invasive vaccine delivery approach using protein nanoparticles.
  • Controlled Delivery of Bio-macromolecules including drug, vaccine and genetic material
  • Multifunctional Nanomedicine
  • Nanoparticles for Cancer Targeting

Selected Publications

  • Paliwal R, Paliwal SR, Agrawal GP, Vyas SP. Biomimetic solid lipid nanoparticles for oral bioavailability enhancement of low molecular weight heparin and its lipid conjugates: in vitro and in vivo evaluation. Mol Pharm. 2011, 8(4):1314-21.
  • Paliwal R, Paliwal SR, Agrawal GP, Vyas SP. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation. Int J Pharm. 2012, 422(1-2):179-84.
  • Paliwal R, Paliwal SR, Agrawal GP, Vyas SP. Recent advances in search of oral heparin therapeutics. Med Res Rev. 2012, 32(2):388-409.
  • Paliwal R, Paliwal SR, Mishra N, Mehta A, Vyas SP. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. Int J Pharm. 2009, 380(1-2):181-8.
  • Paliwal R, Rai S, Vaidya B, Khatri K, Goyal AK, Mishra N, Mehta A, Vyas SP. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine. 2009, 5(2):184-91.